Genetic polymorphisms of BDNF on cognitive functions in drug-naive first episode patients with schizophrenia
Abstract Brain-derived neurotrophic factor (BDNF) is reported to be involved in cognitive decline in patients with schizophrenia (SZ). Previous studies have found that cognitive deficits remain stable during the chronic disease phase in SZ, but the findings were inconsistent. The role of BDNF in cog...
Guardado en:
Autores principales: | Xiuru Su, Limin Qiao, Qing Liu, Yujie Shang, Xiaoni Guan, Meihong Xiu, Xiangyang Zhang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6a05cba8e94c4e2089138ecc119d8f9e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Differential Cortical Gray Matter Deficits in Adolescent- and Adult-Onset First-Episode Treatment-Naïve Patients with Schizophrenia
por: Chengcheng Zhang, et al.
Publicado: (2017) -
Relationship between TNF-α levels and psychiatric symptoms in first-episode drug-naïve patients with schizophrenia before and after risperidone treatment and in chronic patients
por: Chen Lin, et al.
Publicado: (2021) -
COMT polymorphism regulates the hippocampal subfield volumes in first-episode, drug-naive patients with major depressive disorder
por: Otsuka Y, et al.
Publicado: (2019) -
Structural and functional brain abnormalities in drug-naive, first-episode, and chronic patients with schizophrenia: a multimodal MRI study
por: Wu F, et al.
Publicado: (2018) -
No association between cortical dopamine D2 receptor availability and cognition in antipsychotic-naive first-episode psychosis
por: Maria Lee, et al.
Publicado: (2021)